1. Home
  2. KORE vs ACET Comparison

KORE vs ACET Comparison

Compare KORE & ACET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KORE Group Holdings Inc.

KORE

KORE Group Holdings Inc.

HOLD

Current Price

$4.89

Market Cap

83.3M

ML Signal

HOLD

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

HOLD

Current Price

$8.41

Market Cap

71.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KORE
ACET
Founded
2003
1947
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
83.3M
71.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
KORE
ACET
Price
$4.89
$8.41
Analyst Decision
Hold
Strong Buy
Analyst Count
1
5
Target Price
$5.00
$65.33
AVG Volume (30 Days)
50.4K
206.2K
Earning Date
11-12-2025
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$285,408,000.00
N/A
Revenue This Year
$1.26
N/A
Revenue Next Year
$7.55
N/A
P/E Ratio
N/A
N/A
Revenue Growth
0.06
N/A
52 Week Low
$2.00
$7.15
52 Week High
$5.03
$17.44

Technical Indicators

Market Signals
Indicator
KORE
ACET
Relative Strength Index (RSI) 59.25 76.82
Support Level $4.54 $7.76
Resistance Level $5.03 $8.55
Average True Range (ATR) 0.22 0.48
MACD -0.01 -0.13
Stochastic Oscillator 81.38 50.37

Price Performance

Historical Comparison
KORE
ACET

About KORE KORE Group Holdings Inc.

Kore Group Holdings Inc provides Internet of Things (IoT) solutions and services. In addition to providing critical services to customers globally, it enables them to manage, deploy, and scale their IoT applications and use cases. It offers connectivity services, location-based services, device solutions, and managed and professional services for the development and support of IoT technology for the Machine-to-Machine market. It derives revenue from IoT Connectivity services, IoT Solutions services, SIMs (IoT Connectivity), and IoT devices (IoT Solutions). Geographically, the company generates the majority of its revenue from the United States and the rest from other countries.

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

Share on Social Networks: